Dabomb Protein Capital Reinvestment Ratio
Dabomb Protein capital reinvestment ratio. Dabomb Protein (6578) has a Capital Reinvestment Ratio of 2.53x as of March 2025, meaning it reinvests 3% of its operating cash flow (NT$8.12 Million) in capital expenditures (NT$20.59 Million). See Dabomb Protein (6578) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Dabomb Protein (2015–2025)
Capital reinvestment ratio of Dabomb Protein from 2015 to 2025. This chart tracks Dabomb Protein's Capital Reinvestment Ratio across 10 annual periods. See Dabomb Protein free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Dabomb Protein Capital Reinvestment Ratio by Year (2015–2025)
Dabomb Protein capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see Dabomb Protein cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.26x | NT$16.65 Million | NT$37.69 Million | ▲ +255.1% |
| 2024 | 0.64x | NT$47.55 Million | NT$30.32 Million | ▼ -78.0% |
| 2023 | 2.90x | NT$6.51 Million | NT$18.87 Million | ▲ +183.6% |
| 2022 | 1.02x | NT$19.71 Million | NT$20.16 Million | ▼ -25.1% |
| 2020 | 1.37x | NT$13.41 Million | NT$18.31 Million | ▼ -50.5% |
| 2019 | 2.76x | NT$33.26 Million | NT$91.81 Million | ▼ -62.6% |
| 2018 | 7.39x | NT$22.07 Million | NT$163.06 Million | ▲ +94.7% |
| 2017 | 3.79x | NT$43.87 Million | NT$166.46 Million | ▲ +143.9% |
| 2016 | 1.56x | NT$59.58 Million | NT$92.71 Million | ▲ +3977.6% |
| 2015 | 0.04x | NT$139.78 Million | NT$5.33 Million | — |